Christopher L. Amling M.D., F.A.C.S

Background

Dr. Christopher L. Amling, FACS, is the John Barry Professor and Chair of the Department of Urology at Oregon Health & Science University (OHSU) where he also serves as Director of Robotic Surgery for the OHSU Health System.  He grew up in southwestern Oregon, received his undergraduate education from the University of Oregon and his medical degree at OHSU.  He did his surgery and urology residency training at Duke University Medical Center and then completed a fellowship in urologic oncology at the Mayo Clinic.  Dr. Amling served in the US Navy for 20 years, attaining the rank of Captain.  Before coming to OHSU in 2009, he was Program Director and Chair of Urology at the Naval Medical Center in San Diego and then Chief of the Division of Urology at the University of Alabama at Birmingham.

Dr. Amling has a longtime interest in resident training and experience in the development and assessment of resident evaluation tools.  He served on the Urology Residency Review Committee (RRC) for six years and has been a member of other national committees related to resident education including the ACGME Urology Milestones Project Committee and the ACGME Advisory Committee on Educational Outcome Assessment.  Dr. Amling was Chair of the Fellowship Committee for the Society of Urologic Oncology and also served as President of the Society of University Urologists.

In addition to his committee work with the WSAUA, Dr. Amling has served on several national AUA committees including the Education Council, Research Council and the Public Media Committee. He is the recipient of the AUA Gold Cystoscope Award in 2009, a prestigious award given to a urologist who has made important contributions to the specialty within 10 years of completing residency training.  He has been elected for membership to multiple professional organizations including the American Surgical Association (ASA), the Western Urologic Forum (WUF), the American Association of Genitourinary Surgeons (AAGUS) and the Clinical Society of Genitourinary Surgeons (CSGUS).   He currently serves as a Trustee of the American Board of Urology.  Dr. Amling has contributed over 230 peer-reviewed publications, most of which have focused on prostate cancer risk assessment and treatment outcomes.  His clinical practice focuses on the utilization of robotic surgery for the treatment of genitourinary malignancies.